‘Don’t Apologize for Commercialization’: Biotech Legend Robert Langer Urges Pitt to Take More Risks
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
The University of Pittsburgh Office of Innovation and Entrepreneurship (OIE) teamed with its counterparts... Read more
Renerva’s main focus is to develop and commercialize implantable technologies to improve the outcome of peripheral nerve repair procedures. The company is committed to developing the next generation of surgical solutions to improve peripheral nerve repair, accelerate healing following a nerve injury, and improve nerve function following injury and repair.